Leveraging our deeply engaged, well characterized national patient cohort, CURES partners with life science, pharma, biotech, and medical device companies to accelerate the development of neurodegenerative treatments, spanning discovery stage lab services, clinical trial services, and real world evidence data and analytics. Land the rebrand and new website this fall, then run the brand day to day: caregiver-first messaging, condition-specific pages for ALS, Parkinson's, and Alzheimer's/dementia, and proof everywhere - outcomes data, testimonials, partner logos, press, and our founders' story.